is compound tirzepatide banned Compounded Zepbound copycats remain online despite

In recent years, the class has been shown to have increased risks of gastrointestinal problems, including gastroparesis (stomach paralysis) and bowel obstruction

A higher-dose option is also available (10mg BPC-157, 10mg TB-500, 50mg GHK-Cu) for studies requiring increased peptide concentrations

Safety, side effects, and clinical oversight same drug class, different oversight models All GLP-1 receptor agonists, and tirzepatide as a GIP/GLP-1 dual agonist, share a documented side-effect profile

Appetite and food cravings gradually return to pre-treatment levels within 24 weeks

We expect continued legal action from brand companies

Its important to remember that this is not a cure for obesity